Back to Trades
Total Value
$16.7M
Net $7.5M sold
Filing Date
Jun 17, 2026
4 transactions
Sales
$7.5M
4 transactions
Trade Summary
On Jun 15, 2026, Guttman-McCabe Christopher, Chief Reg & Comm Officer, sold $16.7M of Anterix Inc. (ATEX) across 4 transactions. The filing covers Common Stock and reflects net selling of $7.5M. Reported prices ranged from $25.75 to $84.29. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Anterix Inc.
- Ticker Symbol
- ATEX
- CIK
- 0001304492
Insider Information
- Role
- Chief Reg & Comm Officer
- Location
- WOODLAND PARK, NJ
Filing Details
- Filing Date
- Jun 17, 2026
- Transaction Date
- Jun 15, 2026
- Accession Number
- 0001828490-26-000008
- Form Type
- 4
- Net Trading Amount
- -$7.5M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | 11,750 | $25.75 | Exercise | $302.6K |
| Jun 15, 2026 | Common Stock | 8,000 | $32.50 | Exercise | $260.0K |
| Jun 15, 2026 | Common Stock | 50,876 | $34.40 | Exercise | $1.8M |
| Jun 15, 2026 | Common Stock | 20,000 | $37.42 | Exercise | $748.4K |
| Jun 15, 2026 | Common Stock | 6,715 | $42.14 | Exercise | $283.0K |
| Jun 15, 2026 | Common Stock | 25,511 | $49.39 | Exercise | $1.3M |
| Jun 15, 2026 | Common Stock | 35,321 | $81.32 | Sale | $2.9M |
| Jun 15, 2026 | Common Stock | 26,411 | $82.27 | Sale | $2.2M |
| Jun 15, 2026 | Common Stock | 16,381 | $83.72 | Sale | $1.4M |
| Jun 15, 2026 | Common Stock | 13,324 | $84.29 | Sale | $1.1M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Jun 15, 2026 | ATEX derivative | 11,750 | $25.75 | Exercise | $302.6K |
| Jun 15, 2026 | ATEX derivative | 8,000 | $32.50 | Exercise | $260.0K |
| Jun 15, 2026 | ATEX derivative | 50,876 | $34.40 | Exercise | $1.8M |
| Jun 15, 2026 | ATEX derivative | 20,000 | $37.42 | Exercise | $748.4K |
| Jun 15, 2026 | ATEX derivative | 6,715 | $42.14 | Exercise | $283.0K |
| Jun 15, 2026 | ATEX derivative | 25,511 | $49.39 | Exercise | $1.3M |
Want live alerts when Guttman-McCabe Christopher trades again?
Download Insider Trades to track ATEX, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.98 to $81.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- (F2)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.99 to $82.89, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- (F3)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.06 to $84.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- (F4)The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.07 to $84.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the ranges set forth in this footnote to this Form 4.
- (F5)The option shares are fully vested.